Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 77

Results For "REACH"

909 News Found

Salesforce and Azim Premji Foundation launch VaxIT app to speed up Covid-19 vaccination
Public Health | December 21, 2021

Salesforce and Azim Premji Foundation launch VaxIT app to speed up Covid-19 vaccination

The VaxIT app, developed on the Salesforce platform for Azim Premji Foundation and its partners, captures the status of vaccinations to help individuals plan and stay updated on their progress


Gamaleya claims the Sputnik V perfect booster against Omicron
News | December 20, 2021

Gamaleya claims the Sputnik V perfect booster against Omicron

Sputnik Light as a booster significantly increases virus-neutralizing activity against Omicron based on sera 2-3 months after revaccination and is a universal booster to other vaccines inducing stronger antibody and T-cell response


2022: Predictions for medical and healthcare industry
Opinion | December 20, 2021

2022: Predictions for medical and healthcare industry

2022 is going to be the year of opportunities and innovations from the medical industry in India


TeleRay and Radiobotics to provide radiology AI
News | December 20, 2021

TeleRay and Radiobotics to provide radiology AI

TeleRay partners with Radiobotics, adding Artificial Intelligence to their pre-existing integrated best-in-class medical image and patient information distribution platform


Philips instals 1000 active cath labs in India
Medical Device | December 13, 2021

Philips instals 1000 active cath labs in India

Over the next few years, Philips aims to double the number of its active cath labs in India with a special focus on improving accessibility to quality cardiac and neurovascular care in tier 2 and tier 3 cities


Cipla aims to improve access to nebulisers in PHCs
Public Health | December 11, 2021

Cipla aims to improve access to nebulisers in PHCs

The company will donate 5000 nebulizers to primary health care centres in rural India


Zydus receives  USFDA  approval for Phase2(b)/3 trial of Saroglitazar
Biotech | December 10, 2021

Zydus receives USFDA approval for Phase2(b)/3 trial of Saroglitazar

Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)


Algorithmic Biologics receives CE mark for Tapestry platform
Startup | December 10, 2021

Algorithmic Biologics receives CE mark for Tapestry platform

The platform’s technology works as a compression algorithm for molecular testing


Redcliffe Labs chalks out aggressive expansion plans
Diagnostic Center | December 08, 2021

Redcliffe Labs chalks out aggressive expansion plans

It plans to add over 1000 employees over the next six months


Olympus lays out its plans for growth in the medical business
Digitisation | December 08, 2021

Olympus lays out its plans for growth in the medical business

Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected